PI3K class II α regulates δ-opioid receptor export from the trans-Golgi network

Daniel J Shiwarski1,2, Marlena Darr1, Cheryl A Telmer1

  • 1Department of Biological Sciences, Carnegie Mellon University, Pittsburgh, PA 15213.

Insights

This study reveals a novel Golgi checkpoint regulating the surface delivery of delta opioid receptors (δR). Phosphoinositide-3 kinase C2 alpha (PI3K C2A) is crucial for this process in neuronal cells.

Area of Science:

  • Cell Biology
  • Neuroscience
  • Molecular Pharmacology

Background:

  • G protein-coupled receptors (GPCRs) signaling and trafficking are primarily studied via endocytosis.
  • Regulation of newly synthesized GPCRs' surface delivery by extracellular signals remains largely unknown.

Purpose of the Study:

  • To investigate the regulation of delta opioid receptor (δR) surface delivery by extracellular signals.
  • To identify signaling pathways controlling GPCR export from the Golgi.

Main Methods:

  • Utilized PC12 cells and primary trigeminal ganglion neurons.
  • Employed phosphoinositide-3 kinase (PI3K) inhibition and depletion (PI3K C2A).
  • Used nerve growth factor (NGF) treatment and optogenetics for pathway manipulation.

Main Results:

  • Inhibition of PI3K blocked δR export from the Golgi to the cell surface.
  • Depletion of PI3K C2A, but not class I PI3K, inhibited δR export and attenuated receptor function.
  • NGF treatment displaced PI3K C2A; optogenetic recruitment induced δR export.
  • PI3K C2A expression promoted endogenous δR export in neurons.

Conclusions:

  • PI3K C2A is essential and sufficient for δR export and surface delivery in neuronal cells.
  • Identified a novel Golgi export checkpoint regulated by PI3K C2A.
  • Suggests PI3K C2A coordinates GPCR surface delivery via a new Golgi export mechanism.

Related Concept Videos

Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
5.4K
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
15.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.9K
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
8.4K
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
2.4K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.9K